Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Research & Discovery » Proteomics & Protein Research » Serenex Founders Hope Proteomics Leads to Serendipitous Target and Drug Discovery

Serenex Founders Hope Proteomics Leads to Serendipitous Target and Drug Discovery

May 27, 2002
Premium

TWO YEARS ago, while serving as executive vice president in charge of separations products at Dyax, Robert Dishman realized he had to find a way to get involved in the blossoming field of proteomics. With a PhD in chemistry from the University of Massachusetts, Amherst, where he made a specialty of high-performance liquid chromatography, he could see that proteomics had the potential to contribute to speeding the timeline of drug discovery.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Officially Notified

The US has sent its formal notice of withdrawal from the World Health Organization, according to the Wall Street Journal.

Starting With Bit of a Raise

Science reports that a draft spending bill would increase the US National Institutes of Health budget by 13 percent.

Harvard, MIT File Lawsuit Against Trump Administration

The Harvard Crimson reports that Harvard and MIT are suing the Department of Homeland Security and ICE over the new international student visa policy.

Nucleic Acids Research Studies on Molecular Typing, RNA-DNA Hybrids, Protein-RNA Binding Tools

In Nucleic Acids Research this week: algorithm to determine molecular sequence types and other microbial features, computational method to uncover R-loop structures, and more.

What's Popular?

In Proteomics & Protein Research

  1. Twist Bioscience, Takeda Pharma Partner to Develop Antibodies for Oncology, Rare Diseases

  2. WuXi NextCode, Olink Ink Agreement to Provide Proteomic Assays in China

  3. Cancer Research UK, Abcam Partner to Develop Custom Antibodies for Cancer Research

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.